California

Indiana

                Ask Indiana Assembly to Support SB 255 

The Indiana Senate unanimously (50-0) passed SB 255 on January 27, 2020, and now it heads to the House, sponsored by Health Committee Chair Rep. Cindy Kirchhofer. DPAC joined 10 other national diabetes organizations urging Indiana lawmakers to improve emergency insulin access by repealing the state’s prescription requirement for human insulins. Indiana is the only state that currently prohibits over-the-counter sales of Reli-On, Novolin, and Humulin. Health Committee Chair Ed Charbonneau introduced SB 255 to repeal the prescription requirement.

              CLICK HERE TO CALL THEM AND SHOW YOUR SUPPORT! 

5ae7754cdda07.image